Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARQ 501 + Gemcitabine in Metastatic Pancreatic Adenocarcinoma
NCT00102700Phase 2Completed
- Start
- Jan 2005
- Primary completion
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lapachone in pancreatic adenocarcinoma (PDAC). Started Jan 2005; status: completed.
02
Drugs
lapachone
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00102700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00102700.